{
    "Trade/Device Name(s)": [
        "AtheNA Multi-Lyte\u00ae ToRCH IgG Plus Test System"
    ],
    "Submitter Information": "Zeus Scientific, Inc.",
    "510(k) Number": "K093784",
    "Predicate Device Reference 510(k) Number(s)": [
        "K891781",
        "K891783",
        "K924096",
        "K000238"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LGD",
        "LFX",
        "LFZ",
        "MXJ",
        "MYF"
    ],
    "Summary Letter Date": "July 12, 2010",
    "Summary Letter Received Date": "July 13, 2010",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR866.3780",
        "21CFR866.3510",
        "21CFR866.3175",
        "21CFR866.3305"
    ],
    "Regulation Name(s)": [
        "Toxoplasma gondii serological reagents",
        "Rubella virus serological reagents",
        "Cytomegalovirus serological reagents",
        "Herpes Simplex virus serological reagents",
        "Herpes Simplex 2 serological reagents"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "serology"
    ],
    "Analyte(s)": [
        "Toxoplasma gondii IgG antibodies",
        "Rubella IgG antibodies",
        "Cytomegalovirus IgG antibodies",
        "Herpes Simplex 1 IgG antibodies",
        "Herpes Simplex 2 IgG antibodies"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "AtheNA Multi-Lyte instrument",
        "Luminex Corp instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Multiplex microparticle immunoassay",
        "Enzyme Linked Immunoabsorbent Assay"
    ],
    "Methodologies": [
        "Multiplex immunoassay",
        "Qualitative serological detection"
    ],
    "Submission Type(s)": [
        "Test System",
        "Kit",
        "Software",
        "Instrument",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Zeus Scientific AtheNA Multi-Lyte ToRCH IgG Plus Test System for simultaneous qualitative detection of IgG antibodies to Toxoplasma gondii, Rubella, CMV, HSV-1, and HSV-2 in human serum.",
    "Indications for Use Summary": "Qualitative detection of IgG class antibodies to Toxoplasma gondii, Rubella, CMV, HSV-1, and HSV-2 in human serum; aids assessment of serological status and presumptive diagnosis in sexually active adults and expectant mothers; not for blood donor screening or point of care use.",
    "fda_folder": "Microbiology"
}